James Spicer
Affiliations: | Research Oncology | King's College London, London, UK |
Google:
"James Spicer"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Spicer J, Basu B, Montes A, et al. (2023) Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial. Nature Communications. 14: 4180 |
| Ghorani E, Quartagno M, Blackhall F, et al. (2023) REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment. The Lancet. Oncology. 24: e219-e227 |
| Hughes DJ, Kapiris M, Podvez Nevajda A, et al. (2022) Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study. Cancers. 14 |
| Russell B, Moss C, Papa S, et al. (2020) Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London. Frontiers in Oncology. 10: 1279 |
| Middleton G, Fletcher P, Popat S, et al. (2020) Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer. Nature |
| Maringe C, Spicer J, Morris M, et al. (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. The Lancet. Oncology |
| Middleton G, Fletcher P, Popat S, et al. (2020) The National Lung Matrix Trial of personalized therapy in lung cancer. Nature |
| Torricelli F, Saxena A, Nuamah R, et al. (2020) Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy. European Journal of Cancer (Oxford, England : 1990). 132: 104-111 |
| Spicer J, Basu B, Montes A, et al. (2020) Abstract CT141: Phase 1 trial of MOv18, a first-in-class IgE antibody therapy for cancer Cancer Research. 80 |
| Powell-Tuck C, Crawley D, Karapanagiotou E, et al. (2020) Psychological experiences in patients with lung cancer taking targeted therapies Lung Cancer. 139 |